Announcements Trials
Browse Landscape

Phase

Phase 4 1

Status

Recruiting 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Other 1

Conditions

Obesity 5Prostatic Neoplasms 2Overweight 2Endometrial Neoplasms 2Diabetes Mellitus 2Weight Loss 1Precursor Cell Lymphoblastic Leukemia-Lymphoma 1Polycystic Ovary Syndrome 1Opioid-Related Disorders 1Lymphoma, Follicular 1Insulin Resistance 1Colorectal Neoplasms 1Breast Neoplasms 1

Interventions

Metformin 7Exercise 4Inositol 3semaglutide 2Tablets 2Spironolactone 2Progesterone 2xin-kang 1mirabegron 1mazdutide 1maltodextrin 1drospirenone 1dapagliflozin 1artenimol 1Water 1Vitamin D 1Transcranial Direct Current Stimulation 1Tirzepatide 1Thyroxine 1Thioctic Acid 1Sitagliptin Phosphate 1Quercetin 1Physical Examination 1Observation 1Magnesium 1Liraglutide 1Letrozole 1Ketones 1In Vitro Oocyte Maturation Techniques 1Hydroquinones 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Recruiting × Polycystic Ovary Syndrome × Tirzepatide × Clear all
NCT07326111 2026-01-08

PERIODS

University of Bonn

Phase 4 Recruiting
198 enrolled
Other

Obesity, Polycystic Ovary Syndrome, Overweight

Data powered by HemOnc (CC BY 4.0) Colophon âš¡